Načítá se...
Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs
OBJECTIVE: To determine the costs and consequences of switching asthma patients, managed in primary care, from a twice-daily inhaled corticosteroid (ICS), to either a once-daily or another twice-daily ICS. DESIGN: This was a case-control study based on an interrogation of the General Practice Resear...
Uloženo v:
| Vydáno v: | Prim Care Respir J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6743555/ https://ncbi.nlm.nih.gov/pubmed/16701704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2005.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|